Kyle Cetrulo

COO

Kyle Cetrulo has over 20 years of experience in the regenerative medicine and longevity industry. As the Chief Operating Officer, he brings a wealth of knowledge and expertise to our organization.

Prior to joining Mitrix, Kyle was Founder and CEO of Auxocell Laboratories, Inc., a prominent biotech company, leading the company to profitability through strategic licensing deals with international partners, resulting in a successful acquisition in 2023.

Before his tenure at Auxocell, he worked with public and private cord blood banks from 2000 to 2008, served as the Director of the International Cord Blood Society from 1998 to 2005, and edited two editions of Perinatal Stem Cells (Wiley Press, 2010 and 2013).  In 2013, he founded the 501(c)3 nonprofit, International Perinatal Stem Cell Society, Inc. and successfully hosted the society’s inaugural forum. He recently hosted the 10th Anniversary Congress in May 2023.

He has extensive regulatory experience with numerous presentations to the FDA, including the Center for Biologics Evaluation and Research (CBER) and the Center for Veterinary Medicine.  As a successful entrepreneur and the President of the Society, he is widely recognized as a thought leader and patient advocate for the regenerative medicine industry.